Schedule 13G ownership disclosure
SYROS PHARMACEUTICALS, INC.
Security class unavailable · CUSIP: 87184Q107
Event date: 2020-12-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-321513
- Form type
- SC 13G
- Filer
- Ally Bridge MedAlpha Master Fund L.P.
- CIK
- CIK 1831963
- Filed
- Dec 18, 2020
- Reporting period
- Dec 08, 2020
- Description
- Schedule 13G beneficial ownership